Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.120
-0.110 (-8.94%)
At close: Jan 22, 2026, 4:00 PM EST
1.130
+0.010 (0.89%)
Pre-market: Jan 23, 2026, 8:09 AM EST
Rockwell Medical Revenue
Rockwell Medical had revenue of $15.93M in the quarter ending September 30, 2025, a decrease of -43.75%. This brings the company's revenue in the last twelve months to $75.61M, down -23.56% year-over-year. In the year 2024, Rockwell Medical had annual revenue of $101.49M with 21.38% growth.
Revenue (ttm)
$75.61M
Revenue Growth
-23.56%
P/S Ratio
0.51
Revenue / Employee
$309,742
Employees
244
Market Cap
44.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 101.49M | 17.88M | 21.38% |
| Dec 31, 2023 | 83.61M | 10.80M | 14.84% |
| Dec 31, 2022 | 72.81M | 10.88M | 17.57% |
| Dec 31, 2021 | 61.93M | -266.00K | -0.43% |
| Dec 31, 2020 | 62.20M | 894.00K | 1.46% |
| Dec 31, 2019 | 61.30M | -2.09M | -3.29% |
| Dec 31, 2018 | 63.39M | 6.09M | 10.63% |
| Dec 31, 2017 | 57.30M | 4.02M | 7.54% |
| Dec 31, 2016 | 53.28M | -2.07M | -3.73% |
| Dec 31, 2015 | 55.35M | 1.16M | 2.14% |
| Dec 31, 2014 | 54.19M | 1.81M | 3.45% |
| Dec 31, 2013 | 52.38M | 2.54M | 5.09% |
| Dec 31, 2012 | 49.84M | 876.16K | 1.79% |
| Dec 31, 2011 | 48.97M | -10.59M | -17.78% |
| Dec 31, 2010 | 59.55M | 4.83M | 8.82% |
| Dec 31, 2009 | 54.73M | 3.06M | 5.93% |
| Dec 31, 2008 | 51.67M | 8.62M | 20.03% |
| Dec 31, 2007 | 43.05M | 14.41M | 50.30% |
| Dec 31, 2006 | 28.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Assertio Holdings | 137.35M |
| InterCure | 72.16M |
| Aytu BioPharma | 63.70M |
| Cumberland Pharmaceuticals | 41.28M |
| Zhengye Biotechnology Holding | 21.46M |
| SCYNEXIS | 2.93M |
| TherapeuticsMD | 2.80M |
| BioXcel Therapeutics | 752.00K |
RMTI News
- 3 days ago - Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results - Business Wire
- 11 days ago - Rockwell Medical Adds 30 New Customers in the West - Business Wire
- 18 days ago - Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States - Business Wire
- 2 months ago - Rockwell Medical Appoints Joe Dawson to the Company's Board of Directors - Business Wire
- 2 months ago - Rockwell Medical, Inc. (RMTI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Rockwell Medical Announces Third Quarter 2025 Results - Business Wire
- 2 months ago - Rockwell Medical Names Rashad Brown Vice President, Manufacturing and Supply Chain - Business Wire
- 3 months ago - Rockwell Medical to Exhibit at ASN Kidney Week 2025 - Business Wire